The cost-effectiveness of alternative strategies against HBV in Italy.
Ruggeri
Matteo
M
Facoltà di economia, Università Cattolica del Sacro Cuore, L.go F.Vito 1, 00168 Roma, Italy. mruggeri@rm.unicatt.it
Cicchetti
Americo
A
Gasbarrini
Antonio
A
D006528:Carcinoma, Hepatocellular / Q000191:economics / Q000821:virology; D003362:Cost-Benefit Analysis; D006509:Hepatitis B / Q000191:economics / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008103:Liver Cirrhosis / Q000191:economics / Q000821:virology; D008113:Liver Neoplasms / Q000191:economics / Q000821:virology; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D009010:Monte Carlo Method; D010043:Outcome and Process Assessment, Health Care; D011788:Quality of Life; D012308:Risk Management; D012680:Sensitivity and Specificity
D006514:Hepatitis B Surface Antigens